{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": {
    "pdf_name": "Treanor_et_al.__2011_",
    "source_pdf": "data/clinical_files/Treanor et al. (2011).pdf",
    "total_pages": 7,
    "total_blocks": 97,
    "total_characters": 25468
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 1,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "Vaccine manufacturing using eggs requires specialized facilities, and the ability to scale up egg production for growth in eggs, a process that can be time consuming, is not always successful, and which can select receptor variants that may not be optimally representative of circulating influenza strains [1,2].",
      "relevance_explanation": "This quote directly states that the process of growing flu vaccines in eggs can select for receptor variants that may not match circulating strains, supporting the claim that mutations can develop during production and potentially reduce vaccine effectiveness."
    }
  ],
  "model_used": "gpt-4.1"
}